Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line;Die biallelische Mutation von SOCS-1 verhindert den Abbau von JAK2 und prolongiert die Wirkung von phospho-JAK2 in der mediastinalen B-Zell Lymphomlinie MedB-1.

Verhandlungen der Deutschen Gesellschaft für Pathologie

Volumn 89, Issue , 2005, Pages 234-244

  Barth, T F ^a   Melzner, I ^a   Wegener, S ^a   Bucur, A J ^a   Bruderlein S ^a   Dorsch, K ^a   Hasel, C ^a   Leithauser F ^a   Moller P ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

JAK2 PROTEIN, HUMAN; JANUS KINASE 2; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CHROMOSOME 9; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MEDIASTINUM TUMOR; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRECANCER; TRISOMY;

CHROMOSOMES, HUMAN, PAIR 9; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASE 2; LYMPHOMA, B-CELL; MEDIASTINAL NEOPLASMS; MUTATION; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC; TRISOMY;

EID: 38449094525     PISSN: 00704113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)